Tron Logo
Trade on HitBTC
Like this video
Share this ICO with friends and colleagues

Milestones Iryo

Redefining medical data ownership

Iryo is the world’s first participatory, blockchain driven healthcare economy built on decentralising access to medical records. We’re driving the next generation of healthcare by standardising health-data, employing zero-knowledge encryption and giving medical record ownership back to the patient.

Artificial IntelligenceBig DataHealthPlatformSmart Contract

Latest blog posts

3.7
 13 12 expert ratings
Benchy 3.5
KYC
Experts
3.7
4.2
3.3
Review: coming soon PRO
Unknown
Token
IRYO
Type
Utility
Bonus
Available
Platform
EOS
Accepting
ETH, EOS
Minimum investment
1 ETH
Soft cap
8,000,000 USD
Hard cap
26,000,000 USD
Country
Slovenia
Whitelist/KYC
KYC & Whitelist
Restricted areas
USA, China, South Korea
Visit ICO website
GitHubRedditBitcoinTalkMediumTelegramWWW
Report

We launched IEO listing
About Team Milestones Financial Ratings Whitepaper

Milestones

1
2015

Preliminary research

2
2016

Seed investment

3
2017

Pre ICO

4
2018

ICO, production grade implementations

5
2019

Iryo backbone public release

6
2020

Network expansion

Add to bookmarks
ICO KYC Report
3 members invited
Vasja Bočko
Passed
Tjaša Zajc
Passed
Alberto Malave
Passed
KYC procedure verifies selected/specific team members only. It does not guarantee ICO success nor is a call for investment.
Learn more about KYC
Missing or incorrect data? Let us know.

ICOs that might interest you

Premium4.8

Tycoon

Tycoon serves as a secured interface between professional traders and end users.

25 days 15 hours left
Premium5.0

DogData

EtherBone will be listed on Bitforex one of the world's largest and most reputable Cryp...

Ended
4.8

2local

Tapping into banking with a unique cashback system and a coin designed to rise in value...

118 days 15 hours left
4.6

SaTT

SaTT tokens is a Dapp designed to rule advertising transactions between advertisers an...

149 days 15 hours left

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn more Got it